glp-1 hfpef 🔴GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes & HFpEF⤵️ 🔹GLP-1RA use is associated with improved cardiovascular outcomes in non-obese patients with T2DM and and has an associated incremental benefit Epicardial Fat Paradox and Differential

(Not to mention that navigating a huge cruise ship several times a day left me a bit huffy and puffy!) It was around the time that GLP drugs like Ozempic and Mounjaro were being shown to be really effective for weight loss as well as diabetes control

Heres why they work for medically supervised weight loss: They effectively slow down digestion, helping you feel full longer after meals They prompt the body to increase insulin release and decrease glucagon levels, which work together to reduce appetite Patients typically report fewer food cravings and a reduced need to eat large amounts to feel satisfied

In this study, metformin neither induced cell death nor rescued MG-induced cell death in RINm5F cells (Fig

That is why they work so well

These results are often more pronounced than those achieved through diet and exercise alone, especially in individuals who are obese or have been struggling with weight loss for a long time

Dehydration commonly produces symptoms including fatigue, headache, dizziness, muscle weakness, and general malaise, which patients may interpret as flu-like